These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 7705011

  • 1. [Doxazosin in the treatment of light-to-moderate arterial hypertension in a non-comparative multicenter study].
    Pessina AC.
    Clin Ter; 1995 Jan; 146(1):3-12. PubMed ID: 7705011
    [Abstract] [Full Text] [Related]

  • 2. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [Abstract] [Full Text] [Related]

  • 3. A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group.
    Joglekar SJ, Nanivadekar AS.
    J Assoc Physicians India; 1998 Mar; Suppl 1():52-62. PubMed ID: 11233387
    [Abstract] [Full Text] [Related]

  • 4. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y, Tsuchihashi T, Onaka U, Eto K, Ueno M.
    Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
    [Abstract] [Full Text] [Related]

  • 5. [Reducing blood pressure and modification of coronary risk factors by therapy with doxazosin].
    Hitzenberger G, Ganzinger U.
    Wien Klin Wochenschr; 1993 Apr; 105(13):371-6. PubMed ID: 8351927
    [Abstract] [Full Text] [Related]

  • 6. Prazosin GITS vs atenolol in patients with hypertension and normal lipid profile: a randomized, controlled multicenter study. Hyderabad Hypertension Study Group.
    Joglekar SJ, Jaguste V, Nanivadekar AS.
    J Assoc Physicians India; 1998 Apr; Suppl 1():41-51. PubMed ID: 11233386
    [Abstract] [Full Text] [Related]

  • 7. A long-term study of atenolol and doxazosin in mild and moderate hypertension.
    Talseth T, Westlie L, Daae L.
    J Hum Hypertens; 1990 Oct; 4 Suppl 3():39-44. PubMed ID: 2148194
    [Abstract] [Full Text] [Related]

  • 8. Doxazosin in hypertension: results of a general practice study in 4809 patients.
    Langdon CG, Packard RS.
    Br J Clin Pract; 1994 Oct; 48(6):293-8. PubMed ID: 7848789
    [Abstract] [Full Text] [Related]

  • 9. Effects of fosinopril on the blood pressure and lipid profile of patients undergoing heart transplantation.
    Almenar L, Osa A, Palencia M, Flores A, Sánchez E.
    J Heart Lung Transplant; 1997 Apr; 16(4):454-9. PubMed ID: 9154957
    [Abstract] [Full Text] [Related]

  • 10. [Efficacy and tolerance of doxazosin in the treatment of isolated systolic hypertension in hypertensive patients over 60 years of age].
    Calvo C, López E, Barrio E, Espejo J, Ruiz M, Vega A.
    An Med Interna; 1995 Mar; 12(3):122-6. PubMed ID: 7795118
    [Abstract] [Full Text] [Related]

  • 11. [Doxazosin (alpha 1-adrenoreceptor antagonist) used in primary hypertension and it's beneficial effect on lipid metabolism].
    Sznajderman M, Chotkowska E, Peczkowska M, Sawicki M, Janaszek-Sitkowska H, Wiernikowska-Wegorek I, Galewicz A, Cybulska I.
    Kardiol Pol; 1993 Feb; 38(2):107-11. PubMed ID: 8230980
    [Abstract] [Full Text] [Related]

  • 12. [Efficacy of and tolerance to prolonged release prazosin in patients with hypertension and non-insulin dependent diabetes].
    Hanon O, Giacomino A, Troy S, Bernaud C, Girerd X, Weber S.
    Ann Cardiol Angeiol (Paris); 2000 Oct; 49(7):390-6. PubMed ID: 12555491
    [Abstract] [Full Text] [Related]

  • 13. Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group.
    Zanchetti A.
    Blood Press Suppl; 1995 Oct; 3():38-46. PubMed ID: 8535541
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and tolerability of manidipine hydrochloride in the long-term treatment of mild-moderate hypertension. Manidipine Efficacy in Long-Term Treatment Group.
    Fogari R, Zoppi A, Lusardi P, Mugellini A.
    Blood Press Suppl; 1996 Oct; 5():24-8. PubMed ID: 8973789
    [Abstract] [Full Text] [Related]

  • 15. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH, Kim YD, Lim DS, Yoon MH, Ahn YK, On YK, Lee JW, Kim IJ, Park JB, Kim JJ, Chung WS, Yang JY, Seo HS, Shin EK, Kim HS, Korean Multicenter Amlodipine Study Investigators.
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [Abstract] [Full Text] [Related]

  • 16. Prazosin GITS vs sustained release nifedipine in patients with hypertension and abnormal lipid profile: a randomized, controlled, multicenter study. Madras Hypertension Study Group.
    Misra KP, Joglekar SJ, Mukherjee S, Nanivadekar AS.
    J Assoc Physicians India; 1998 Sep; Suppl 1():30-40. PubMed ID: 11233385
    [Abstract] [Full Text] [Related]

  • 17. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
    Kisicki JC, Fiske K, Lyne A.
    Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 19. Multicentric, clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized, double-blind clinical trial.
    Pathak L, Hiremath, Kerkar PG, Manade VG.
    J Assoc Physicians India; 2004 Mar; 52():197-202. PubMed ID: 15636308
    [Abstract] [Full Text] [Related]

  • 20. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S, Caglar N, Canberk A, Deger N, Demirtas M, Dortlemez H, Kiliccioglu B, Kozan O, Ovunc K, Turkoglu C.
    Curr Med Res Opin; 2003 Mar; 19(3):226-37. PubMed ID: 12803737
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.